---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-24-000842"
form_type: "8-K"
ticker: "ARCT"
cik: "0001768224"
company_name: "Arcturus Therapeutics Holdings Inc."
filed_at: "2024-06-24T23:59:59+00:00"
generated_at: "2026-06-01T02:31:55.961330+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Arcturus Therapeutics appoints Dr. Moncef Slaoui to Board of Directors

## Summary
- Dr. Moncef Slaoui, former Chief Scientific Advisor for Operation Warp Speed, appointed independent director effective June 19, 2024.
- Slaoui brings vaccine industry expertise; previously served on boards of Moderna, Lonza, Vaxcyte, and held leadership at GSK.
- Slaoui will receive standard non-employee director compensation as described in 2024 proxy statement.
- No arrangements or family relationships with other directors/officers; no reportable transactions under Item 404(a).

## SEC filing metadata
- accession: 0001193805-24-000842
- form_type: 8-K
- ticker: ARCT
- cik: 0001768224
- company_name: Arcturus Therapeutics Holdings Inc.
- filed_at: 2024-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000842/0001193805-24-000842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000842/e663734_8k-arct.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-24-000842
- JSON: https://secwatch.observer/filing/0001193805-24-000842.json
- Plain text: https://secwatch.observer/filing/0001193805-24-000842.txt

## Key facts
- Executive change
  Moncef Slaoui was appointed as Member of the Board of Directors at Arcturus Therapeutics Holdings Inc..
  - Action: appointed
  - Role: Member of the Board of Directors
  source text: On June 19, 2024, Dr. Moncef Slaoui, Ph.D., agreed to serve as a member of the Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1768224/000119380524000842/0001193805-24-000842-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.